Form 8-K - Current report:
SEC Accession No. 0001558370-25-002906
Filing Date
2025-03-13
Accepted
2025-03-13 16:10:10
Documents
16
Period of Report
2025-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20250313x8k.htm   iXBRL 8-K 36404
2 EX-99.1 gbio-20250313xex99d1.htm EX-99.1 142440
3 GRAPHIC gbio-20250313xex99d1001.jpg GRAPHIC 6132
  Complete submission text file 0001558370-25-002906.txt   319169

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20250313.xsd EX-101.SCH 4050
5 EX-101.DEF gbio-20250313_def.xml EX-101.DEF 2736
6 EX-101.LAB gbio-20250313_lab.xml EX-101.LAB 13968
7 EX-101.PRE gbio-20250313_pre.xml EX-101.PRE 10834
18 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250313x8k_htm.xml XML 4660
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 25735845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)